Delivery Order SPE2DR25D2010-SPE2DR26F4ZBY
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Rexulti 2 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $74,612.17. This non-competitive delivery order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be delivered to AmerisourceBergen's facility in...
- The Defense Logistics Agency awarded a delivery order valued at $23,642.73 to AmerisourceBergen Drug Corp for Rexulti 2 mg tablets (30-count) on July 30, 2025, with an ultimate completion date of July 31, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Rexulti (brexpiprazole) is a prescription antipsychotic medication used in treating major...
- The Defense Logistics Agency awarded a delivery order valued at $4,171.92 to AmerisourceBergen Drug Corp for the supply of Rexulti 0.25 mg tablets (30-count) on November 10, 2025, with an ultimate completion date of November 12, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Rexulti (brexpiprazole) is an atypical antipsychotic medication used in...
- The Defense Logistics Agency awarded a delivery order valued at $7,613.10 to AmerisourceBergen Drug Corp for the supply of Rexulti 1 mg tablets (quantity: 30 count) under a firm fixed price contract. This non-competitive delivery order was issued on August 1, 2025, with an ultimate completion date of August 4, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Rexulti (brexpiprazole) is an atypical antipsychotic medication used to treat schizophrenia and...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $4,195.59 by the Defense Logistics Agency (DLA) on September 9, 2025, for the supply of Rexulti 2 mg tablets (30-count packages). The contract carries a firm fixed price structure with no set-aside designation, indicating the award was made through open competition. The order is scheduled for completion by September 10, 2025, with performance conducted from the vendor's Corporate Office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,018.24 on November 28, 2025, for the supply of Rexulti (brexpiprazole) 2 mg tablets in a 30-count package. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by December 1, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $16.79K to AmerisourceBergen Drug Corp for supply of Rexulti (brexpiprazole) 1 mg tablets in a 30-count package. This firm fixed price, non-set-aside delivery order was awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Rexulti is a prescription antipsychotic medication used in treating major depressive disorder and...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $6,433.92 by the Defense Logistics Agency on December 3, 2025, for the supply of Rexulti 1 mg tablets (30-count packages). The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be executed from the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 4, 2025. This award is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $27,896.99 to AmerisourceBergen Drug Corp for the supply of Rexulti 2 mg tablets (30-count units) under a firm fixed-price contract type. The award was made on October 27, 2025, with an ultimate completion date of October 28, 2025, and represents a non-competitive set-aside delivery against an existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Rexulti 0.5 mg tablets (30-count packages) valued at $14,929.95 with a firm fixed price structure. This delivery order represents a competitive award with no set-aside designation and is set to conclude by August 11, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work from its Corporate Office...
- SPE2DR25D2010Indefinite Delivery Contract
- SPE2DR25D2010-SPE2DR26F4ZBYDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $24,852.15 to AmerisourceBergen Drug Corp for the supply of Rexulti 1 mg tablets (30-count) on December 2, 2025, with completion scheduled for December 3, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Rexulti (brexpiprazole) is an atypical antipsychotic medication used in treating major depressive disorder and schizophrenia, representing part of the company's broader pharmaceutical distribution services to federal healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive $999.99 billion global pharmaceutical support vehicle that extends through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp supplies a wide range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military and veteran healthcare systems. The company's federal contract awards demonstrate consistent capability in meeting competitive procurement requirements across multiple therapeutic domains and delivery scenarios.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.9k | 12/1/25 |